Exact Sciences (EXAS) Revenue Breakdown: Q3 2025 Business & Regional Performance
Exact Sciences (EXAS) reported total revenue of 850.74M USD in Q3 2025, with its core business segment Screening contributing 78.31%. Regionally, United States remained the largest market, accounting for 93.09% of total revenue. Explore Exact Sciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.